Gene deletion: a new target for cancer chemotherapy
- 1 September 1993
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 342 (8872) , 662-664
- https://doi.org/10.1016/0140-6736(93)91764-d
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndromeCancer, 1991
- Nonrandom structural and numerical chromosome changes in non‐small‐cell lung cancerGenes, Chromosomes and Cancer, 1991
- Molecular themes in oncogenesisCell, 1991
- Lack of expression of aminoacylase-1 in small cell lung cancer. Evidence for inactivation of genes encoded by chromosome 3p.Journal of Clinical Investigation, 1989
- Clinical Pharmacology of 5-FluorouracilClinical Pharmacokinetics, 1989
- Functional inactivation of genes by dominant negative mutationsNature, 1987
- A null allele of esterase D is a marker for genetic events in retinoblastoma formationHuman Genetics, 1987
- Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.Journal of Clinical Oncology, 1986
- Familial Pyrimidinemia and Pyrimidinuria Associated with Severe Fluorouracil ToxicityNew England Journal of Medicine, 1985
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971